TTM Posts Record Q3 Sales of $1.2B, Guides Q4 to $1.42-1.44B and Sets 2027 Sales Target of $6.5-6.75B
TTMI sits 82% above its 52-week low of $54.43.
Summary
TTM reported record Q3 2026 sales of $1.2 billion (+60% year on year) and non-GAAP EPS of $1.46, then guided Q4 to $1.42-1.44 billion in sales and issued an initial 2027 forecast of $6.5-6.75 billion in sales and $8.10-8.90 in non-GAAP EPS.
Key Events · Earnings and Guidance · TTMI
-
Record Q3 Sales of $1.2 Billion
Net sales rose 60% year on year to $1,203.9 million from $752.7 million, an all-time quarterly record, with Data Center and Networking up 115% and Medical, Industrial and Instrumentation up 97%.
-
Non-GAAP EPS of $1.46, EBITDA Margin 20.1%
GAAP net income was $84.8 million, or $0.79 per diluted share; non-GAAP net income was $157.8 million, or $1.46 per diluted share, and adjusted EBITDA reached $242.3 million, or 20.1% of net sales.
-
Q4 Guidance of $1.42-1.44 Billion in Sales
Fourth-quarter 2026 non-GAAP EPS is guided to $1.77-$1.83, bringing full year 2026 to $4.47-$4.49 billion in net sales and $4.97-$5.03 in non-GAAP EPS, including the closed STG and Epiq acquisitions and related financing costs.
-
Initial 2027 Forecast: $6.5-6.75 Billion Sales
Preliminary 2027 guidance calls for net sales of $6.5-$6.75 billion and non-GAAP EPS of $8.10-$8.90, including closed acquisitions but excluding planned or potential deals not yet closed.
Analysis · TTMI · Manufacturing
Every line that matters set a record in the third quarter: net sales of $1.2 billion (up 60% year on year), non-GAAP EPS of $1.46 and an adjusted EBITDA margin above 20% for the first time. The bigger news is forward-looking. Fourth-quarter guidance of $1.42-1.44 billion in sales and $1.77-1.83 in non-GAAP EPS implies a further step up from Q3, and the company's first 2027 forecast of $6.5-6.75 billion in sales and $8.10-8.90 in EPS is well above the 2026 run rate of roughly $4.5 billion and $5.00. That outlook already folds in the closed STG and Epiq acquisitions and their financing costs, so the growth is not purely acquisition arithmetic. Management also said net leverage was 2.8x pro-forma adjusted EBITDA at September 30 and expects to be back inside the 1.5-2.0x target range by the time the $650 million Ophir Optics deal closes, which addresses the main worry created by three acquisitions in quick succession. Execution is the risk: the guidance assumes continued AI data-center demand (Data Center and Networking was 41% of sales, up 115%) and that a $2.0 billion A&D backlog holds, and any slip in either would hit a stock that has already been re-rated.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 36.8% of the 1026 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.78%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TTMI was trading at $99.00 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $10.8B. The 52-week trading range was $54.43 to $223.83. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.